DaVita (DVA) Stock Price, Fundamentals & Analysis

What DVA does

DaVita (DVA) is a US stock in the Healthcare sector, specifically the Medical Care Facilities industry. The company provides kidney dialysis services for patients with chronic kidney failure, operating outpatient dialysis centers and offering hemodialysis in clinics, hospitals, and at home. It also runs clinical laboratories, provides disease management and integrated care services, and offers physician services and transplant software. DaVita was incorporated in 1994 and is headquartered in Denver, United States, employing 78,000 people.

Key numbers explained

• The current price is 183.14 USD, down 0.32% today. Over the last 52 weeks, the stock traded between 101 and 247.49, a 37.5% gain from a year ago.
• The trailing P/E ratio of 15.5 compares the share price to the last 12 months of earnings; the forward P/E ratio of 10.6 uses expected future earnings, often seen as a gauge of growth expectations.
• Earnings per share (trailing 12 months) is 11.79 USD, meaning the company earned that amount per share over the year.
• The dividend yield is 0%, and 0% of earnings are paid out as dividends, so the company currently returns cash to shareholders only through share price appreciation.
• The beta of 0.83 suggests the stock tends to move less than the overall market; a beta below 1 is often interpreted as lower volatility.
• Revenue (trailing 12 months) is 14.01 mld. USD, growing 5.2% year over year, while the profit margin is 6% and the operating margin is 16.1%.
• The return on equity of 88.5% indicates how efficiently the company uses shareholders' equity to generate profit.
• The debt-to-equity ratio of 1,242% shows the level of debt relative to equity, a metric often used to assess financial leverage.

Recent news

Headlines include "Is DaVita Stock Underperforming the S&P 500?", which compares DVA to the broader market, and "DaVita HealthCare (DVA) Advances While Market Declines", noting relative strength. Other titles mention a BofA price target adjustment to 180 from 170, a community care report on career development, and a monthly portfolio update from AllianceBernstein.

What to watch

Investors typically monitor how DVA moves relative to peers like Amgen (AMGN), Cooper Companies (The) (COO), and Quest Diagnostics (DGX), as well as broader indices such as the S&P 500. Factors that often affect healthcare facility stocks include changes in Medicare and Medicaid reimbursement rates, regulatory policy, labor costs, and patient volume trends. The next earnings report is scheduled for 28 oct. 2026, which is a common date to watch for updated guidance and financial results.